← All organizations
Highest phase reached
Phase 3
First clinical trial
May 1, 2008Last known activity
Nov 9, 2020
Timeline
1990s
- Jan 1, 1995
Athersys, Inc— Founded
Drugs by trial phase (3 distinct, 11 trials)
Phase 3 (1 own, 0 via acquisition)
Phase 2 (2 own, 0 via acquisition)
Indications
Studied for
- Acute Lung Injury
- Cerebral Infarction
- Colitis
- Colitis, Ulcerative
- Infarction
- Ischemia
- Leukemia
- Leukemia, Myelogenous, Chronic, BCR-ABL Positive
- Multiple Organ Failure
- Myelodysplastic Syndromes
- Myocardial Infarction
- Obesity
- Preleukemia
- Respiratory Distress Syndrome
- Respiratory Distress Syndrome, Newborn
- Stroke
- Syndrome
- Systemic Inflammatory Response Syndrome
- Ulcer
- Weight Loss
- Wounds and Injuries
Recent trials (15)
- NCT04533464Lead sponsorPhase 2Nov 9, 2020
- NCT04367077Study directorPhase 2/Phase 3Apr 28, 2020
- NCT04367077Lead sponsorPhase 2/Phase 3Apr 28, 2020
- NCT03545607Study directorPhase 3Jul 31, 2018
- NCT03545607Lead sponsorPhase 3Jul 31, 2018
- NCT02611609Lead sponsorPhase 1/Phase 2Jan 1, 2016
- NCT02611609CollaboratorPhase 1/Phase 2Jan 1, 2016
- NCT02277613Lead sponsorPhase 2Jun 1, 2015
- NCT01841632CollaboratorPhase 1Apr 1, 2013
- NCT01436487Lead sponsorPhase 2Oct 1, 2011
- NCT01436487Study directorPhase 2Oct 1, 2011
- NCT01240915CollaboratorPhase 2Feb 1, 2011
- NCT00735683Lead sponsorPhase 2Sep 1, 2008
- NCT00677859Lead sponsorPhase 1Jul 1, 2008
- NCT00677222Lead sponsorPhase 1May 1, 2008
Details
- Founded
- Cleveland, OH, US Jan 1, 1995
- Last known activity
- Nov 9, 2020